William L. Dewey

Affiliations: 
Virginia Commonwealth University School of Medicine, Richmond, VA 
Area:
pharmacology, analgesics, opioids
Google:
"William Dewey"
Mean distance: 16.04 (cluster 32)
 
SNBCP
Cross-listing: Chemistry Tree

BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Sierra S, Lippold KM, Stevens DL, et al. (2020) Adjunctive effect of the serotonin 5-HT receptor agonist lorcaserin on opioid-induced antinociception in mice. Neuropharmacology. 107949
Mischel RA, Muchhala KH, Dewey WL, et al. (2019) The "culture" of pain control: A review of opioid-induced dysbiosis (OID) in antinociceptive tolerance. The Journal of Pain : Official Journal of the American Pain Society
Ma H, Obeng S, Wang H, et al. (2019) Application of Bivalent Bioisostere Concept on Design and Discovery of Potent Opioid Receptor Modulators. Journal of Medicinal Chemistry
Hill R, Roberts J, Maclachlan J, et al. (2019) Prolonged ethanol administration prevents the development of tolerance to morphine-induced respiratory depression. Drug and Alcohol Dependence. 205: 107674
Hill R, Santhakumar R, Dewey W, et al. (2019) Fentanyl depression of respiration: comparison with heroin and morphine. British Journal of Pharmacology
Komla E, Stevens DL, Zheng Y, et al. (2019) Experimental colitis enhances the rate of antinociceptive tolerance to morphine via peripheral opioid receptors. The Journal of Pharmacology and Experimental Therapeutics
Akbarali HI, Dewey WL. (2019) Gastrointestinal motility, dysbiosis and opioid-induced tolerance: is there a link? Nature Reviews. Gastroenterology & Hepatology
Obeng S, Jali A, Zheng Y, et al. (2019) Characterization of 17-Cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(indole-7-carboxamido)morphinan (NAN) as a Novel Opioid Receptor Modulator for Opioid Use Disorder Treatment. Acs Chemical Neuroscience
Zheng Y, Obeng S, Wang H, et al. (2019) Design, Synthesis, and Biological Evaluation of the Third Generation 17-Cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-[(4'- pyridyl)carboxamido]morphinan (NAP) Derivatives as Mu/Kappa Opioid Receptor Dual Selective Ligands. Journal of Medicinal Chemistry
Obeng S, Wang H, Jali A, et al. (2018) Structure activity relationship studies of 6α- and 6β-indolylacetamidonaltrexamine derivatives as bitopic mu opioid receptor modulators and elaboration of the 'message-address concept' to comprehend their functional conversion. Acs Chemical Neuroscience
See more...